Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HIF-1a activation mediates resistance to anti-angiogenic therapy in neuroblastoma xenografts.

HIF-1a activation mediates resistance to anti-angiogenic therapy in neuroblastoma xenografts. J Pediatr Surg. 2013 Jan; 48(1):39-46.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.